Newspaper Advertisement of Unaudited Financial Results for the Quarter ended 30th June, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Link Pharma Chem Limited submitted copies of its unaudited financial results for the quarter ended 30 June 2025, as published in Business Standard (English) and Loksatta (Gujarati) on 2 August 2025, in compliance with SEBI Listing Regulations. Total income from operations fell to Rs. 656.45 lakh from Rs. 911.80 lakh in the same quarter last year, a drop of roughly 28% year-on-year. The company swung from a profit of Rs. 29.64 lakh after tax in Q1 FY25 to a loss of Rs. 35.02 lakh after tax in Q1 FY26, translating to a negative EPS of Rs. 0.79 versus Rs. 0.67 a year ago. The full-year FY25 had also closed in the red with a loss of Rs. 102.73 lakh after tax on revenue of Rs. 2,561.99 lakh.
Weak set of numbers for retail investors: revenue shrank and the company slipped back into a loss, reversing the small profit it made in the year-ago quarter. Continued losses alongside the negative EPS suggest pressure on profitability in the near term, though the filing itself is only a regulatory disclosure of results already filed.